Listen for Gliptin Patients Complaining of Severe Joint Pain

A new FDA warning will spur questions about whether gliptins (Januvia, Onglyza, etc) cause severe joint pain.

This risk seems to be a class effect of gliptins, and it's very rare...but the pain can be disabling.

We know these diabetes meds inhibit dipeptidyl peptidase-4 (DPP-4) enzyme that breaks down incretin hormones.

Get concise advice on drug therapy, plus unlimited access to CE

Pharmacist's Letter includes:

  • 12 issues every year, with brief articles about new meds and hot topics
  • 200+ CE courses, including the popular CE-in-the-Letter
  • Quick reference drug comparison charts
  • Access to the entire archive

Already a subscriber? Log in

Volume pricing available. Get a quote